Phase 2 Study: Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Prader-Willi Syndrome [IND 121109 acknowledged 8/27/14]

Medicine & Life Sciences

1. Prader-Willi Syndrome 100%
2. Oxytocin 67%
3. Hyperphagia 51%
4. Placebos 25%
5. Rare Diseases 11%
6. Compulsive Behavior 11%
7. Censuses 8%
8. Population 6%
9. Food Addiction 6%
10. Peptide YY 5%
11. Hormones 5%
12. Orphaned Children 5%
13. Pancreatic Polypeptide 5%
14. Child 5%
15. Quality of Life 5%
16. Pediatrics 5%
17. Weights and Measures 5%